Thioperamide is a potent and selective H3-receptor antagonist, whose in vivo effects have been reported after systemic administration. Some questions have arisen about its ability to cross the blood-brain barrier, since different experimental conditions have given different results in rats, namely a low brain/blood ratio at low doses (10 mg/Kg) and a much higher one at higher doses (60 mg/Kg). In this work we demonstrate the dose-dependence of thioperamide pharmacokinetics, measuring its plasma and cerebral levels after i.p. administration of different doses to rats. Both the plasma half-life and brain penetration of thioperamide resulted as being dose-dependent: when administered to 80 g body weight Wistar rats at 10 mg/Kg i.p., the drug has a short half life (120') and a rather poor brain penetration, but increasing the dose (to 20, 40 and 60 mg/Kg) gives rise to a prolongation of its persistence in the blood (up to 600' at highest dose) and a higher brain penetration. Also, the profile of the plasma concentration curve varies from the dose of 10 to that of 20 mg/Kg, passing from a mono-exponential decrease to a more complex one characterized by an apparent distribution phase. The different distribution processes can be interpreted in the light of thioperamide protein binding and affinity for lipophilic tissues: protein binding can prevent brain penetration (but not distribution to other tissues) at lower doses, while at higher doses the free plasma fraction increases and it can allow passive distribution to lipophilic tissues such as brain tissues. A re-distribution from these tissues and plasma is probably responsible for the strong increase in half-life at high doses.